Search by Drug Name or NDC

    NDC 00641-0410-12 Heparin Sodium 10000 [USP'U]/mL Details

    Heparin Sodium 10000 [USP'U]/mL

    Heparin Sodium is a INTRAVENOUS; SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is HEPARIN SODIUM.

    Product Information

    NDC 00641-0410
    Product ID 0641-0410_9102e900-98b0-4afa-b6af-e1908e81f08f
    Associated GPIs 83100020202035
    GCN Sequence Number 006544
    GCN Sequence Number Description heparin sodium,porcine VIAL 10000/ML INJECTION
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 25697
    HICL Sequence Number 002810
    HICL Sequence Number Description HEPARIN SODIUM,PORCINE
    Brand/Generic Generic
    Proprietary Name Heparin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Heparin Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 10000
    Active Ingredient Units [USP'U]/mL
    Substance Name HEPARIN SODIUM
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA017037
    Listing Certified Through 2024-12-31

    Package

    NDC 00641-0410-12 (00641041012)

    NDC Package Code 0641-0410-12
    Billing NDC 00641041012
    Package 25 VIAL in 1 PACKAGE (0641-0410-12) / 1 mL in 1 VIAL (0641-0410-37)
    Marketing Start Date 1972-03-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.80552
    Pricing Unit ML
    Effective Date 2023-10-18
    NDC Description HEPARIN SODIUM 10,000 UNIT/ML VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis